The postmarketing safety profile of varicella vaccine
- 1 November 2000
- Vol. 19 (7-8) , 916-923
- https://doi.org/10.1016/s0264-410x(00)00297-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Postlicensure effectiveness of varicella vaccine during an outbreak in a child care centerPublished by American Medical Association (AMA) ,1997
- The Epidemiology of Varicella and Its ComplicationsThe Journal of Infectious Diseases, 1995
- Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax®) in healthy adolescents and adultsVaccine, 1995
- Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reactionThe Journal of Pediatrics, 1994
- The vaccine adverse event reporting system (VAERS)Vaccine, 1994
- Cost-effectiveness of a routine varicella vaccination program for US childrenPublished by American Medical Association (AMA) ,1994
- Live attenuated varicella vaccine: Evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virusThe Journal of Pediatrics, 1990
- Herpes Zoster in an Adult Recipient of Live Attenuated Varicella VaccineThe Journal of Infectious Diseases, 1989
- Centers for Disease ControlThe Pediatric Infectious Disease Journal, 1984
- Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950–1981: I. EpidemiologyAnnals of Neurology, 1984